Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sam who wrote (2209)	10/7/1997 11:05:00 PM
From: Henry Niman	of 6136

sam, Thestreet.com actually ran two AGPH articles today. The first was before the close and it gave some predictions (all lower than reported). After the close, they updated the article with the actual numbers and indicated that AGPH was trading at $54 after hours which was in contrast to last quarter when the earnings increase was muted by tax concerns. They gave a breakdown of Japan Tobacco's share and explained the thinking behind long and short positions. Longs saw the earnings as strong and getting stronger. Shorts looked at slowing PI sales, competition from dual protease protocols, and new data suggesting that none of the PIs would successfully pave the way for positive salvage therapy with second PI.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next